Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1924-2025

Azure S DR MRI SureScan, Product number W3DR01 Recall

Azure S DR MRI SureScan, Product number W3DR01

FDA recall Class II

Ongoing

FDA lists this Class II recall for Azure S DR MRI SureScan, Product number W3DR01. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1924-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 29, 2025
FDA report date
Jun 18, 2025
Quantity in commerce
6
Distribution
See key details
FDA cause
Process change control

What is being recalled?

Azure S DR MRI SureScan, Product number W3DR01

Affected model & UDI checker

Search the exact identifiers published for Z-1924-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedAzure S DR MRI SureScan, Product number W3DR01Check source notice00763000956004
FDA code information

Serial numbers RNJ108800G, RNJ108808G, RNJ108810G UDI-DI 00763000956004 ***Updated 10/14/25*** Scope expanded to include implanted devices, serial numbers: RNJ108803G RNJ108804G RNJ108820G

View the original FDA recall notice

Why was this product recalled?

Identified devices may experience sudden battery power failure without alarm, power supply power-on-resets, and interruption of therapy. Potential patient harms include insufficient pacing support leading to cardiac arrest, syncope, or hospitalization; or system revision (explant/replacement) leading to infection, hematoma, or temporary impairment.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Medtronic, Inc. take?

Firm notified consignees of the recall on April 29, 2025 via letters titled "Urgent Medical Device Recall". Customers were instructed to identify the affected product and return to Medtronic. If you have any questions regarding this communication, please contact your Medtronic Field Representative ***Updated 10/14/25*** Firm expanded action to include three implanted devices. Consignees were notified on September 29, 2025. Consignees were instructed to utilize the CareLink remote monitoring system and inform a Medtronic Representative if a return of patient symptoms occurs or any unexpected device behaviors occur, including but not limited to: device resets or unexpected pacing diagnostics, with or without an alert. If the clinician assesses that prophylactic replacement of the device is necessary, standard warranty will apply. Medtronic will provide a replacement Azure S DR and a TYRXTM absorbable antibacterial envelope at no cost.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology